LON:FUM Futura Medical (FUM) Share Price, News & Analysis GBX 0.42 +0.04 (+10.00%) As of 07/31/2026 12:10 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock About Futura Medical Stock (LON:FUM) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Futura Medical alerts:Sign Up Key Stats Today's Range 0.34▼ 0.4250-Day Range 0.34▼ 0.7452-Week Range 0.24▼ 13.45Volume3.59 million shsAverage Volume9.69 million shsMarket Capitalization£2.43 millionP/E RatioN/ADividend Yield4.55%Price TargetN/AConsensus RatingN/A Company Overview Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products. Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40. Around 60% of women experience at least one symptom of sexual dysfunction, and only one in four women seek professional help, and remain chronically underserved. Eroxon®, Futura's clinically proven lead product, has been developed for the treatment of Erectile Dysfunction ("ED"). The highly differentiated product, which is the only topical gel treatment for ED available over the counter and helps men get an erection in ten minutes, addresses significant unmet needs in the ED market. Eroxon® has been nominated for a number of healthcare industry awards and has won two to-date. Futura has distribution partners in place in a number of major consumer markets including Haleon in the US, the largest market for ED in the world, and Cooper Consumer Health in Europe. WSD4000 is a topical treatment designed for the symptoms of impaired sexual response and function in women. There is currently no regulatory approved OTC treatment available for impaired sexual response and function in women. WSD4000 has the potential to be an effective, breakthrough treatment for the common symptoms associated with impaired sexual response and function, such as lack of desire, arousal and lubrication. Read More Receive FUM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Futura Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FUM Stock News HeadlinesFutura Medical gets greenlight for stronger product "Eroxon Intense"July 31 at 7:10 AM | finance.yahoo.comFutura Medical: US Eroxon deal and WSD4000 breakthrough - ICYMIJuly 11, 2026 | finance.yahoo.comBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to move out of overpriced AI stocks before the tech trade breaks down and into lesser-known names with real potential to challenge the Mag 7. One pick he calls 'an upgrade to Tesla stock' is a little-known company that just inked a partnership with Nvidia, positioning it ahead of Tesla in the autonomous vehicle race. | Chaikin Analytics (Ad)Futura to appeal European patent decisionJuly 8, 2026 | finance.yahoo.comFutura Medical reports 'highly positive' data for female sexual health treatmentJune 30, 2026 | ca.finance.yahoo.comFutura Medical Reshapes U.S. Eroxon Strategy with New MPG Distribution Partnership (FUM)June 29, 2026 | uk.finance.yahoo.comFutura Medical refines strategy and evolves commercial model after tough 2025April 29, 2026 | finance.yahoo.comFutura Medical Regulatory NewsApril 17, 2026 | lse.co.ukSee More Headlines FUM Stock Analysis - Frequently Asked Questions How have FUM shares performed this year? Futura Medical's stock was trading at GBX 1.12 at the beginning of 2026. Since then, FUM stock has decreased by 62.7% and is now trading at GBX 0.42. How were Futura Medical's earnings last quarter? Futura Medical plc (LON:FUM) released its quarterly earnings results on Wednesday, April, 29th. The company reported ($2.78) EPS for the quarter. The company had revenue of $1.70 million for the quarter. Futura Medical had a negative net margin of 534.62% and a negative trailing twelve-month return on equity of 310.00%. How do I buy shares of Futura Medical? Shares of FUM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Futura Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Futura Medical investors own include Indivior (INDV), Tullow Oil (TLW), Lloyds Banking Group (LLOY), Bigblu Broadband (BBB), BP (BP), Directa Plus (DCTA) and Genel Energy (GENL). Company Calendar Last Earnings4/29/2026Today8/02/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolLON:FUM CIKN/A Webwww.futuramedical.com Phone+44-1483-685670FaxN/AEmployees12Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX (2.78) Trailing P/E RatioN/A Forward P/E Ratio0.15 P/E GrowthN/ANet Income-£3.88 million Net Margins-534.62% Pretax MarginN/A Return on Equity-310.00% Return on Assets-26.59% Debt Debt-to-Equity RatioN/A Current Ratio2.06 Quick Ratio5.73 Sales & Book Value Annual Sales£1.70 million Price / Sales1.43 Cash FlowGBX 0.02 per share Price / Cash Flow20.43 Book ValueGBX 2.59 per share Price / Book0.16Miscellaneous Outstanding Shares581,328,000Free FloatN/AMarket Cap£2.43 million OptionableNot Optionable Beta0.02 10 Best Stocks to Own - Summer 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free Report This page (LON:FUM) was last updated on 8/3/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredElon's new "super startup"Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...Banyan Hill Publishing | SponsoredWhere to Put $100 Before Trump's New Tech Law Rolls OutThe Financial Times says a new tech law puts America 'on the verge of a financial revolution.' Yahoo Finance e...Brownstone Research | Sponsored“The unseen winner of the AI race” is not SpaceXMarc Chaikin - the analyst who called Nvidia before its historic run - says a tech firm labeled 'the unseen wi...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Futura Medical plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Futura Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
